← Back to news
Y

Yahoo Finance

XRP ETF Inflows Hit $1.55 Billion Record Amid 70% Price Surge

Y

Bitcoin’s Rare Fractal Suggests $100K BTC Price Target

Y

One Sentence in the Fed Meeting Minutes Is Nightmare Fuel for Fed Chair Kevin Warsh and the Stock Market

Y

Global Bond Yields Fall on Declining Oil, Prospects of Further Treasury Action

Y

Samsung Falls 8.7% After Record $79 Billion Payout Disappoints

Y

XRP News: Price Rally, Take Profit or Let It Run?

Y

ICYMI: Trump’s Stock Trades

Y

Nvidia Earnings, Jackson Hole: What to Watch This Week

Y

I've Covered Semiconductors for Years. Nvidia Is My No. 1 Pick Heading Into 2027.

Y

Stock market today: S&P 500, Nasdaq fall as chip stocks sink, US unveils new Iran sanctions

Y

Prediction: UPS Dividend Remains Frozen Through 2027

Y

US Dollar Price Forecast: Fiscal Risks Weigh on DXY; EUR/USD and GBP/USD Test Key Resistance

Y

The WSJ Dollar Index Rises 0.13% to 95.45

Y

Gold Above $4,700 Ahead of Inflation Data, Fed Chair Speech

Y

Oil Falls Ahead of Bessent’s Press Conference

Y

Exxon Eyes Shell’s $8 Billion U.S. Chemicals Business

Y

Equinor and Uniper Sign 15-Year Gas Supply Deal for Germany

Y

Ask an Advisor: I Pay a 0.75% Fee on $1.5M Invested. How Do I Know If It's Worth It?

Y

World shares decline as bond market pressure persists, and Iran's rial sinks against the dollar

Y

T. Rowe Price Bets Big on Fixed Income With F/m Deal

Y

Why Passive Inflows May be Pulling Down Active Fund Performance

Y

Dimensional, Allspring Latest Firms to Tack on ETF Share Classes

Y

Oil drops more than $2 despite new US sanctions on Iran

Y

Walmart stock price target reset by JPMorgan after earnings

Y

Ampol Profit Surges as Middle East Disruption Boosts Refining Margins

Y

Alibaba shares fall 8% after $10 billion Hong Kong share sale

Y

Gold, silver rally off ugly crash, but investors remain on edge

Y

Alibaba shares slide after $10.2 billion AI share sale offered at sharp discount

Y

AbbVie’s Humira Replacement Strategy Is Working, But Could Growth Be Too Concentrated?

Y

Pfizer vs. Johnson & Johnson: Which Pharma Giant Is Better Prepared for Its Patent Cliff?

Y

Duos Technologies’ AI Transformation Has Wall Street’s Attention. Here’s How Big This $300 Million Market Cap Company Could Get.

Y

Zoetis Wins Emergency Authorization for Simparica Trio, Can It Support a Slowing U.S. Business?

Y

Samsung Electronics shares skid as record shareholder returns disappoint

Y

Gilead’s Core Business Is Accelerating, But Will Its $11 Billion Pipeline Bet Pay Off?

Y

AstraZeneca’s Earnings Beat Shows Momentum, But Can its Pipeline Deliver $80 Billion in Revenue?

Y

Novo Nordisk Expands Its AI Push With AWS, But Can It Accelerate Drug Discovery?

Y

Nissan scrapped a bank it couldn't afford to build

Y

Micron, Sandisk, and SK Hynix: History Says This About the Memory Trio's Rally

Y

Abbott vs. Intuitive Surgical: Which MedTech Stock Offers Better Long-Term Upside?

Y

Fabrinet Just Lost Billions in Market Value Due to Nvidia. Here’s Why the Reaction Is Overdone.

Y

You Can Now Deduct Car Loan Interest but Only if the Final Assembly Happened in America. Here’s How to Check If a Car Qualifies

Y

Alkane Resources uncovers new high-grade gold-antimony domain at Costerfield

Y

The AI Debt Boom Is Helping Push Everyone’s Cost of Capital Higher

Y

Gilead’s HIV Business is Surging, but is the Company Too Dependent on One Franchise?

Y

Pfizer’s Turnaround is Gaining Traction, but Can New Products Offset its Patent Cliff?

Y

Retirees can supplement their Social Security with two top dividend stocks

Y

Is Johnson & Johnson’s $5.5 Billion Talc Settlement a Buy Signal, or Is the Legal Risk Far From Over?

Y

Diesel Crisis Threatens to Outlast the Middle East War

Y

Bitwise Just Took $1.8 Billion in a Bear Market, Tom Lee Noticed

Y

A Tax Strategy So Aggressive It Built the World’s Largest Hedge Fund and Made Losing Money the Hottest Product on Wall Street

Y